2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol(CAS: 137330-52-0)

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and the European Chemicals Agency’s (ECHA) REACH regulations. Additionally, it is subject to FDA and EPA guidelines for chemical control and management. Producers and handlers must ensure compliance with specific hazard categories and notification requirements under these regulatory frameworks.

Synthetic alternatives include isomers and analogs such as 2-(2,4-Difluorophenyl)-3-(5-chloro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol or 2-(2,4-Difluorophenyl)-3-(5-methyl-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol. Other substitutes might involve using different functional groups or other heterocycles in the synthesis.

The market trend indicates growing interest in this compound due to its potential applications in pharmaceuticals and agrochemicals. Research is focusing on its bioavailability, pharmacokinetics, and efficacy. Additionally, there is a trend towards exploring its use in novel drug discovery and as a lead compound in various therapeutic areas.

Waste containing this compound should be managed according to hazardous waste regulations. It should be collected in appropriate containers, labeled, and stored separately to prevent environmental contamination. For disposal, professional waste treatment facilities are recommended, and incineration is often a preferred method. Proper protective measures and safety protocols must be followed during handling to ensure worker safety and environmental protection.